CSRxP Statement on Potential Big Pharma Bailout

“Only Big Pharma would use bipartisan opioid legislation as another opportunity to make money off the very crisis they themselves created. The focus of this effort […]

Read more

CSRxP Urges FDA To Finalize Guidance Critical To Lower Drug Prices

The Campaign for Sustainable Rx Pricing (CSRxP) today joined more than a dozen health care organizations in sending a letter to U.S. Food and Drug Administration […]

Read more

CSRxP Letter of Support for Durbin-Grassley DTC Advertising Amendment

Last night, Senators Durbin and Grassley filed an amendment to the Labor-HHS appropriations bill that would provide funding to enable the Department of Health and Human […]

Read more

CSRxP Applauds Trump Administration’s Focus on Out-of-Control Drug Prices

CSRxP spokesman Will Holley released the following statement applauding the Trump Administration’s focus on out-of-control drug prices on the 100th day since the release of the Blueprint to […]

Read more